We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Safety monitoring and information (121)
- Compliance and enforcement (32)
- Import and export (28)
- Shortages and supply disruptions (17)
- Sunscreens (7)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
1112 result(s) found, displaying 1001 to 1025
-
Market actionsThis is an update to the alert issued by the TGA on 16 June 2011. Johnson and Johnson have advised the TGA of additional serial numbers affected by the recall.
-
Market actions
-
Safety alerts
-
Market actionsSpecific packs of Avaira Toric contact lenses are being recalled by CooperVision Australia Pty Ltd
-
Market actionsAbout Octagam 5%: lifting of the voluntary recall
-
Safety alerts
-
Safety alerts
-
Market actionsThe Therapeutic Goods Administration (TGA) has been advised that TRIAD Sterile Lubricating Jelly, 3g sachet, with lot numbers beginning with 7, 8, 9 or 0, is being recalled as it may not have been properly sterilised.
-
Safety alerts
-
-
-
Market actionsRecall of IGC Dorel Safety 1st Complete Healthcare Kit: Thermometer
-
Safety alerts
-
Safety alertsWe are advising that Movectro (cladribine) has been withdrawn from supply in Australia due to commercial reasons.
-
Safety alerts
-
Safety alerts
-
Safety alertsWe are reviewing the safety of the Pneumovax 23 vaccine due to reports of severe local reactions and have updated our revaccination recommendations.
-
Safety alerts
-
Safety alertsConcerns have been expressed that a range of breast screening devices based on technologies other than mammography have not been appropriately assessed for their safety or accuracy.
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alertsOn 26 January 2011, the US Food and Drug Administration (FDA) announced a safety communication to warn about an association between breast implants and anaplastic large cell lymphoma. The risk of a patient developing this type of lymphoma is very low.